Back to Results
First PageMeta Content
HIV/AIDS / Microbiology / Medicine / Biology / Virology / Hepatitis / Viral load / Innogenetics / Viral diseases / Hepatitis C / Medical tests


Xagenic Announces $6 Million Genome Canada Funded Project in Partnership with University of Toronto Toronto, ON (October 15, 2014) – Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular
Add to Reading List

Document Date: 2014-10-14 12:21:53

Open Document

File Size: 130,82 KB

Share Result on Facebook

City

Toronto / /

Company

Xagenic Inc. / Domain Associates / BDC Capital / Ontario Capital Growth Corporation / CTI Life Sciences Fund / /

Currency

USD / /

/

Event

Funding / FDA Phase / /

Facility

University of Toronto Toronto / University of Toronto / /

IndustryTerm

detection technology / substrate chip / rapid front-line nucleic acid testing / /

MedicalCondition

resultant liver disease / disease / hepatitis C / HCV / chronic HCV infection / /

Organization

World Health Organization / University of Toronto Toronto / University of Toronto / Ontario Ministry of Research and Innovation / /

Person

Graham D. Jack / Shana Kelley / Edward Sargent / Ihor Boszko / /

/

Position

forward to the development / Director of Research and Development / Vice President of Business Development / Vice President / Business Development ihor.boszko@xagenic.com / /

Product

Low Cost / /

ProvinceOrState

Ontario / /

Technology

substrate chip / incartridge AuRA™ detection technology / detection technology / genotyping / genotype / /

URL

http /

SocialTag